Immuron working towards US FDA approval of Traveler’s Diarrhea product Travelan

Immuron Limited CEO Steven Lydeamore joined Steve Darling from Proactive to share news about the Australian Biotech company that is looking at using its technology for product development around gut health

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.